Loading…
Therapeutic efficacy of antimalarial drugs targeting DosRS signaling in Mycobacterium abscessus
A search for alternative treatments led to our interest in the two-component regulator DosRS, which, in , is required for the bacterium to establish a state of nonreplicating, drug-tolerant persistence in response to a variety of host stresses. We show here that the genetic disruption of impairs the...
Saved in:
Published in: | Science translational medicine 2022-02, Vol.14 (633), p.eabj3860-eabj3860 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | A search for alternative
treatments led to our interest in the two-component regulator DosRS, which, in
, is required for the bacterium to establish a state of nonreplicating, drug-tolerant persistence in response to a variety of host stresses. We show here that the genetic disruption of
impairs the adaptation of
to hypoxia, resulting in decreased bacterial survival after oxygen depletion, reduced tolerance to a number of antibiotics in vitro and in vivo, and the inhibition of biofilm formation. We determined that three antimalarial drugs or drug candidates, artemisinin, OZ277, and OZ439, can target DosS-mediated hypoxic signaling in
and recapitulate the phenotypic effects of genetically disrupting
. OZ439 displayed bactericidal activity comparable to standard-of-care antibiotics in chronically infected mice, in addition to potentiating the activity of antibiotics used in combination. The identification of antimalarial drugs as potent inhibitors and adjunct inhibitors of
in vivo offers repurposing opportunities that could have an immediate impact in the clinic. |
---|---|
ISSN: | 1946-6234 1946-6242 1946-3242 |
DOI: | 10.1126/scitranslmed.abj3860 |